Ibd CAncer and seRious Infections in France (I-CARE 2)

RecruitingOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

March 1, 2031

Study Completion Date

March 1, 2031

Conditions
IBDUlcerative ColitisCrohn Disease
Interventions
OTHER

Non-interventional

This study is non-interventional, patients will be enrolled when initiating a treatment through standard of care procedures.

Trial Locations (2)

75012

RECRUITING

APHP Hôpital Saint Antoine, Paris

80000

RECRUITING

CHU Amiens Picardie, Amiens

All Listed Sponsors
collaborator

Sanoia

OTHER

lead

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

OTHER